| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Abnormalities, Multiple | 94 | 2021 | 232 | 9.410 |
Why?
|
| Brain | 152 | 2022 | 2216 | 8.040 |
Why?
|
| Nervous System Malformations | 38 | 2023 | 46 | 6.520 |
Why?
|
| Mutation | 136 | 2022 | 3967 | 6.420 |
Why?
|
| Cerebellum | 50 | 2023 | 247 | 6.400 |
Why?
|
| Microcephaly | 50 | 2019 | 75 | 5.770 |
Why?
|
| Malformations of Cortical Development | 31 | 2022 | 39 | 5.710 |
Why?
|
| Intellectual Disability | 51 | 2022 | 186 | 4.810 |
Why?
|
| Cerebral Cortex | 55 | 2021 | 584 | 4.750 |
Why?
|
| Brain Diseases | 41 | 2021 | 180 | 4.380 |
Why?
|
| Megalencephaly | 16 | 2021 | 21 | 4.370 |
Why?
|
| Lissencephaly | 15 | 2022 | 22 | 4.230 |
Why?
|
| Hydrocephalus | 20 | 2023 | 101 | 4.120 |
Why?
|
| Epilepsy | 43 | 2023 | 397 | 3.710 |
Why?
|
| Developmental Disabilities | 36 | 2023 | 195 | 3.700 |
Why?
|
| Phenotype | 111 | 2022 | 2378 | 3.430 |
Why?
|
| Mutation, Missense | 38 | 2022 | 276 | 3.370 |
Why?
|
| Microtubule-Associated Proteins | 37 | 2022 | 176 | 3.320 |
Why?
|
| Child, Preschool | 142 | 2021 | 3611 | 3.270 |
Why?
|
| Infant | 131 | 2021 | 3045 | 3.200 |
Why?
|
| Child | 164 | 2022 | 6926 | 2.950 |
Why?
|
| Syndrome | 102 | 2020 | 446 | 2.770 |
Why?
|
| Eye Abnormalities | 23 | 2019 | 41 | 2.610 |
Why?
|
| Dandy-Walker Syndrome | 17 | 2023 | 20 | 2.600 |
Why?
|
| Magnetic Resonance Imaging | 117 | 2022 | 3357 | 2.530 |
Why?
|
| Humans | 428 | 2023 | 86617 | 2.330 |
Why?
|
| Spasms, Infantile | 11 | 2018 | 30 | 2.150 |
Why?
|
| Craniofacial Abnormalities | 13 | 2020 | 36 | 2.120 |
Why?
|
| Infant, Newborn | 66 | 2021 | 2378 | 2.100 |
Why?
|
| Autistic Disorder | 10 | 2021 | 147 | 2.100 |
Why?
|
| Male | 272 | 2021 | 40958 | 2.100 |
Why?
|
| Chromosome Deletion | 30 | 2016 | 229 | 2.070 |
Why?
|
| Female | 275 | 2021 | 44509 | 2.040 |
Why?
|
| Polymicrogyria | 9 | 2021 | 10 | 1.980 |
Why?
|
| Nerve Tissue Proteins | 26 | 2018 | 503 | 1.980 |
Why?
|
| Agenesis of Corpus Callosum | 19 | 2021 | 25 | 1.900 |
Why?
|
| Phosphatidylinositol 3-Kinases | 12 | 2022 | 262 | 1.860 |
Why?
|
| Adolescent | 112 | 2021 | 8979 | 1.810 |
Why?
|
| Cerebellar Diseases | 6 | 2021 | 20 | 1.770 |
Why?
|
| Classical Lissencephalies and Subcortical Band Heterotopias | 9 | 2022 | 13 | 1.650 |
Why?
|
| Tubulin | 10 | 2022 | 58 | 1.640 |
Why?
|
| Genetic Predisposition to Disease | 33 | 2020 | 2270 | 1.630 |
Why?
|
| Neurodevelopmental Disorders | 10 | 2022 | 36 | 1.630 |
Why?
|
| Cell Movement | 17 | 2018 | 758 | 1.580 |
Why?
|
| X Chromosome | 21 | 2014 | 152 | 1.580 |
Why?
|
| Mosaicism | 11 | 2019 | 67 | 1.580 |
Why?
|
| Neurocutaneous Syndromes | 8 | 2019 | 12 | 1.570 |
Why?
|
| Genetic Linkage | 28 | 2012 | 623 | 1.480 |
Why?
|
| Capillaries | 6 | 2013 | 91 | 1.460 |
Why?
|
| Pedigree | 73 | 2020 | 966 | 1.440 |
Why?
|
| Neurons | 29 | 2021 | 1546 | 1.420 |
Why?
|
| Muscular Dystrophies | 17 | 2020 | 54 | 1.400 |
Why?
|
| Genetic Association Studies | 23 | 2021 | 294 | 1.360 |
Why?
|
| Dystonia | 12 | 2020 | 29 | 1.350 |
Why?
|
| Growth Disorders | 10 | 2019 | 63 | 1.340 |
Why?
|
| TOR Serine-Threonine Kinases | 4 | 2022 | 182 | 1.330 |
Why?
|
| Chromosomes, Human, Pair 17 | 19 | 2013 | 110 | 1.310 |
Why?
|
| Rhombencephalon | 6 | 2018 | 50 | 1.310 |
Why?
|
| Homeodomain Proteins | 14 | 2014 | 536 | 1.290 |
Why?
|
| Polydactyly | 8 | 2021 | 8 | 1.280 |
Why?
|
| Proto-Oncogene Proteins c-akt | 8 | 2022 | 322 | 1.230 |
Why?
|
| Chromosome Aberrations | 19 | 2020 | 387 | 1.220 |
Why?
|
| Transcription Factors | 19 | 2021 | 1565 | 1.210 |
Why?
|
| 1-Alkyl-2-acetylglycerophosphocholine Esterase | 22 | 2017 | 35 | 1.210 |
Why?
|
| DNA Mutational Analysis | 46 | 2018 | 526 | 1.160 |
Why?
|
| Neuropeptides | 17 | 2017 | 112 | 1.160 |
Why?
|
| Cerebral Ventricles | 11 | 2016 | 76 | 1.140 |
Why?
|
| Microfilament Proteins | 9 | 2019 | 208 | 1.080 |
Why?
|
| Neuroimaging | 11 | 2022 | 113 | 1.080 |
Why?
|
| Twins, Dizygotic | 3 | 2020 | 40 | 1.060 |
Why?
|
| Genes, Recessive | 15 | 2017 | 87 | 1.050 |
Why?
|
| Skin Abnormalities | 4 | 2018 | 11 | 1.040 |
Why?
|
| Choristoma | 15 | 2007 | 68 | 1.040 |
Why?
|
| Twins, Monozygotic | 4 | 2020 | 57 | 1.000 |
Why?
|
| Gene Duplication | 8 | 2013 | 125 | 0.990 |
Why?
|
| Adult | 92 | 2022 | 25640 | 0.980 |
Why?
|
| Diagnosis, Differential | 15 | 2017 | 1565 | 0.960 |
Why?
|
| Gene Deletion | 15 | 2018 | 329 | 0.950 |
Why?
|
| Mesencephalon | 6 | 2012 | 64 | 0.920 |
Why?
|
| Chromosome Disorders | 14 | 2016 | 114 | 0.910 |
Why?
|
| Forkhead Transcription Factors | 9 | 2017 | 166 | 0.900 |
Why?
|
| Genotype | 35 | 2021 | 1851 | 0.900 |
Why?
|
| Brain Stem | 10 | 2023 | 165 | 0.870 |
Why?
|
| Autism Spectrum Disorder | 3 | 2021 | 76 | 0.840 |
Why?
|
| Psychotic Disorders | 1 | 2023 | 184 | 0.830 |
Why?
|
| Connective Tissue Diseases | 2 | 2013 | 67 | 0.830 |
Why?
|
| Diseases in Twins | 3 | 2020 | 65 | 0.830 |
Why?
|
| Fingers | 2 | 2019 | 68 | 0.810 |
Why?
|
| Terminology as Topic | 4 | 2021 | 217 | 0.790 |
Why?
|
| Zika Virus Infection | 5 | 2019 | 13 | 0.780 |
Why?
|
| Genetics | 1 | 2020 | 24 | 0.770 |
Why?
|
| Fetus | 9 | 2021 | 226 | 0.750 |
Why?
|
| Coloboma | 9 | 2019 | 12 | 0.740 |
Why?
|
| Schizophrenia | 1 | 2023 | 464 | 0.730 |
Why?
|
| Chromosomes, Human, Pair 16 | 6 | 2013 | 79 | 0.730 |
Why?
|
| Genetic Diseases, X-Linked | 5 | 2008 | 34 | 0.720 |
Why?
|
| Animals | 71 | 2023 | 26582 | 0.720 |
Why?
|
| Young Adult | 31 | 2021 | 5974 | 0.720 |
Why?
|
| Genetic Variation | 8 | 2020 | 1351 | 0.710 |
Why?
|
| Sequence Deletion | 12 | 2013 | 205 | 0.710 |
Why?
|
| Gray Matter | 1 | 2019 | 33 | 0.700 |
Why?
|
| Parkinson Disease | 6 | 1999 | 132 | 0.700 |
Why?
|
| Noonan Syndrome | 2 | 2016 | 5 | 0.690 |
Why?
|
| Heterozygote | 20 | 2021 | 365 | 0.690 |
Why?
|
| Conserved Sequence | 3 | 2018 | 210 | 0.680 |
Why?
|
| Central Nervous System Cysts | 1 | 2018 | 9 | 0.680 |
Why?
|
| Axon Guidance | 1 | 2018 | 5 | 0.680 |
Why?
|
| Facies | 13 | 2019 | 27 | 0.680 |
Why?
|
| Pregnancy | 19 | 2020 | 2894 | 0.670 |
Why?
|
| Chromosome Mapping | 26 | 2014 | 1074 | 0.670 |
Why?
|
| Intracranial Arterial Diseases | 1 | 2018 | 3 | 0.670 |
Why?
|
| Cytoskeletal Proteins | 10 | 2021 | 223 | 0.670 |
Why?
|
| Phosphoric Diester Hydrolases | 1 | 2018 | 25 | 0.660 |
Why?
|
| Pyrophosphatases | 1 | 2018 | 16 | 0.660 |
Why?
|
| Costello Syndrome | 3 | 2019 | 3 | 0.660 |
Why?
|
| Alopecia | 3 | 2013 | 34 | 0.650 |
Why?
|
| Zinc | 1 | 2018 | 91 | 0.650 |
Why?
|
| Inheritance Patterns | 3 | 2014 | 48 | 0.650 |
Why?
|
| Neurogenesis | 6 | 2021 | 74 | 0.640 |
Why?
|
| Genetic Testing | 13 | 2017 | 535 | 0.630 |
Why?
|
| Sodium-Potassium-Exchanging ATPase | 5 | 2021 | 78 | 0.620 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 3 | 2019 | 154 | 0.600 |
Why?
|
| Gene Dosage | 6 | 2011 | 207 | 0.590 |
Why?
|
| Chromosomes, Human, Pair 2 | 8 | 2019 | 85 | 0.590 |
Why?
|
| Seizures | 14 | 2022 | 297 | 0.590 |
Why?
|
| Cilia | 7 | 2022 | 29 | 0.590 |
Why?
|
| Loose Anagen Hair Syndrome | 1 | 2016 | 5 | 0.570 |
Why?
|
| Anemia, Sickle Cell | 1 | 2018 | 131 | 0.570 |
Why?
|
| Heart Defects, Congenital | 8 | 2020 | 351 | 0.570 |
Why?
|
| Protein Phosphatase 1 | 1 | 2016 | 34 | 0.560 |
Why?
|
| Class I Phosphatidylinositol 3-Kinases | 9 | 2022 | 56 | 0.560 |
Why?
|
| Genetic Loci | 4 | 2014 | 250 | 0.560 |
Why?
|
| Prenatal Diagnosis | 4 | 2010 | 104 | 0.560 |
Why?
|
| Child Development Disorders, Pervasive | 2 | 2013 | 39 | 0.550 |
Why?
|
| Prosencephalon | 3 | 2012 | 62 | 0.540 |
Why?
|
| 14-3-3 Proteins | 3 | 2013 | 10 | 0.540 |
Why?
|
| Exome | 14 | 2021 | 127 | 0.540 |
Why?
|
| Fetal Diseases | 2 | 2013 | 81 | 0.540 |
Why?
|
| Zika Virus | 5 | 2019 | 14 | 0.540 |
Why?
|
| Hypothalamic Diseases | 1 | 2015 | 2 | 0.530 |
Why?
|
| Molecular Sequence Data | 36 | 2015 | 3030 | 0.530 |
Why?
|
| Mice | 43 | 2023 | 11352 | 0.530 |
Why?
|
| Translocation, Genetic | 13 | 2010 | 265 | 0.530 |
Why?
|
| Craniopharyngioma | 1 | 2015 | 11 | 0.530 |
Why?
|
| Consanguinity | 14 | 2017 | 73 | 0.530 |
Why?
|
| Hominidae | 2 | 2006 | 96 | 0.520 |
Why?
|
| Longevity | 1 | 2015 | 51 | 0.520 |
Why?
|
| Pediatric Obesity | 1 | 2015 | 22 | 0.510 |
Why?
|
| Corpus Callosum | 10 | 2018 | 56 | 0.510 |
Why?
|
| HEK293 Cells | 13 | 2022 | 615 | 0.510 |
Why?
|
| Infant, Premature | 2 | 2016 | 290 | 0.510 |
Why?
|
| Pituitary Neoplasms | 1 | 2015 | 62 | 0.510 |
Why?
|
| DNA Copy Number Variations | 5 | 2021 | 171 | 0.500 |
Why?
|
| Cohort Studies | 19 | 2020 | 2767 | 0.500 |
Why?
|
| Dystonic Disorders | 2 | 2020 | 7 | 0.500 |
Why?
|
| Arthrogryposis | 3 | 2019 | 6 | 0.500 |
Why?
|
| Research | 1 | 2016 | 253 | 0.500 |
Why?
|
| Gene Expression Regulation, Developmental | 7 | 2018 | 623 | 0.490 |
Why?
|
| Weight Gain | 1 | 2015 | 123 | 0.490 |
Why?
|
| Cerebral Hemorrhage | 2 | 2016 | 325 | 0.490 |
Why?
|
| Walker-Warburg Syndrome | 4 | 2017 | 5 | 0.490 |
Why?
|
| Dentate Gyrus | 1 | 2014 | 32 | 0.490 |
Why?
|
| Olivopontocerebellar Atrophies | 4 | 2010 | 6 | 0.490 |
Why?
|
| Syndactyly | 5 | 2016 | 12 | 0.480 |
Why?
|
| Periventricular Nodular Heterotopia | 4 | 2018 | 5 | 0.480 |
Why?
|
| Chromosomes, Human, Pair 22 | 4 | 2016 | 43 | 0.480 |
Why?
|
| Kidney Diseases, Cystic | 5 | 2017 | 23 | 0.470 |
Why?
|
| Cell Cycle Proteins | 9 | 2019 | 388 | 0.470 |
Why?
|
| Histone-Lysine N-Methyltransferase | 3 | 2020 | 154 | 0.470 |
Why?
|
| Eye Diseases | 3 | 2016 | 53 | 0.470 |
Why?
|
| Congenital Abnormalities | 11 | 2020 | 63 | 0.460 |
Why?
|
| Carrier Proteins | 5 | 2019 | 673 | 0.460 |
Why?
|
| Vascular Malformations | 3 | 2020 | 19 | 0.460 |
Why?
|
| Haploinsufficiency | 6 | 2018 | 62 | 0.460 |
Why?
|
| Chromosomes, Human, X | 5 | 2013 | 55 | 0.460 |
Why?
|
| Lipomatosis | 2 | 2016 | 9 | 0.460 |
Why?
|
| Pregnancy Complications, Infectious | 4 | 2018 | 105 | 0.460 |
Why?
|
| Chromosomes, Human, Pair 1 | 7 | 2013 | 100 | 0.450 |
Why?
|
| Child Behavior Disorders | 1 | 2013 | 76 | 0.450 |
Why?
|
| Endoribonucleases | 2 | 2010 | 92 | 0.450 |
Why?
|
| Retrospective Studies | 19 | 2023 | 8477 | 0.440 |
Why?
|
| Amino Acid Sequence | 21 | 2019 | 2062 | 0.440 |
Why?
|
| Spinal Cord | 2 | 2013 | 249 | 0.440 |
Why?
|
| Interneurons | 4 | 2013 | 93 | 0.440 |
Why?
|
| Kidney | 7 | 2012 | 1241 | 0.430 |
Why?
|
| Penetrance | 5 | 2015 | 44 | 0.430 |
Why?
|
| Diagnostic Imaging | 9 | 2017 | 469 | 0.420 |
Why?
|
| Neurobiology | 1 | 2011 | 10 | 0.420 |
Why?
|
| Calcinosis | 5 | 2018 | 224 | 0.420 |
Why?
|
| Dwarfism | 4 | 2016 | 16 | 0.410 |
Why?
|
| Holoprosencephaly | 4 | 2014 | 11 | 0.410 |
Why?
|
| Aicardi Syndrome | 2 | 2011 | 2 | 0.410 |
Why?
|
| Dystroglycans | 5 | 2017 | 15 | 0.410 |
Why?
|
| Dermis | 1 | 2011 | 27 | 0.410 |
Why?
|
| Receptor, Platelet-Derived Growth Factor beta | 3 | 2020 | 28 | 0.400 |
Why?
|
| Vesico-Ureteral Reflux | 4 | 2021 | 28 | 0.400 |
Why?
|
| Chromosomes, Human, Pair 7 | 3 | 2009 | 79 | 0.390 |
Why?
|
| Precision Medicine | 1 | 2015 | 395 | 0.380 |
Why?
|
| Base Sequence | 26 | 2017 | 2330 | 0.380 |
Why?
|
| Retina | 3 | 2017 | 213 | 0.380 |
Why?
|
| Alleles | 14 | 2022 | 1128 | 0.370 |
Why?
|
| In Situ Hybridization, Fluorescence | 15 | 2012 | 348 | 0.370 |
Why?
|
| Proteins | 10 | 2012 | 777 | 0.370 |
Why?
|
| Paleopathology | 2 | 2006 | 5 | 0.370 |
Why?
|
| Body Size | 3 | 2009 | 91 | 0.370 |
Why?
|
| Sacrum | 1 | 2009 | 40 | 0.350 |
Why?
|
| Cells, Cultured | 13 | 2020 | 2818 | 0.350 |
Why?
|
| Hemimegalencephaly | 2 | 2022 | 2 | 0.350 |
Why?
|
| Septo-Optic Dysplasia | 2 | 2011 | 6 | 0.350 |
Why?
|
| Hearing Loss, Sensorineural | 1 | 2009 | 46 | 0.350 |
Why?
|
| Stroke | 1 | 2018 | 965 | 0.340 |
Why?
|
| Genes, Dominant | 10 | 2008 | 117 | 0.340 |
Why?
|
| Family Health | 10 | 2018 | 162 | 0.340 |
Why?
|
| Central Nervous System Vascular Malformations | 1 | 2009 | 32 | 0.340 |
Why?
|
| Adaptor Proteins, Signal Transducing | 6 | 2018 | 302 | 0.340 |
Why?
|
| Contractile Proteins | 6 | 2006 | 54 | 0.340 |
Why?
|
| Lymphatic Abnormalities | 2 | 2021 | 8 | 0.340 |
Why?
|
| Rectum | 1 | 2009 | 146 | 0.330 |
Why?
|
| Age of Onset | 9 | 2020 | 310 | 0.330 |
Why?
|
| X Chromosome Inactivation | 3 | 2012 | 28 | 0.330 |
Why?
|
| Cyclin D2 | 2 | 2021 | 19 | 0.330 |
Why?
|
| Trinucleotide Repeat Expansion | 2 | 2007 | 19 | 0.330 |
Why?
|
| Models, Molecular | 11 | 2021 | 1286 | 0.320 |
Why?
|
| Membrane Transport Proteins | 1 | 2009 | 166 | 0.320 |
Why?
|
| Polymorphism, Single Nucleotide | 15 | 2018 | 2357 | 0.320 |
Why?
|
| Point Mutation | 9 | 2013 | 246 | 0.310 |
Why?
|
| Membrane Proteins | 8 | 2010 | 1196 | 0.310 |
Why?
|
| Actins | 5 | 2022 | 451 | 0.300 |
Why?
|
| Intelligence | 2 | 2001 | 71 | 0.300 |
Why?
|
| Homozygote | 9 | 2018 | 200 | 0.300 |
Why?
|
| Eye | 3 | 2019 | 111 | 0.300 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 2 | 2018 | 87 | 0.300 |
Why?
|
| Laminin | 4 | 2020 | 85 | 0.300 |
Why?
|
| Hydrops Fetalis | 2 | 2019 | 16 | 0.290 |
Why?
|
| Chromosomes, Human, Pair 6 | 5 | 2013 | 125 | 0.290 |
Why?
|
| Frontal Lobe | 3 | 2004 | 130 | 0.280 |
Why?
|
| Genetic Counseling | 4 | 2000 | 100 | 0.280 |
Why?
|
| Tumor Suppressor Proteins | 2 | 2020 | 279 | 0.280 |
Why?
|
| History, 21st Century | 2 | 2020 | 175 | 0.280 |
Why?
|
| Genitalia, Male | 2 | 2005 | 24 | 0.280 |
Why?
|
| Cognitive Dysfunction | 2 | 2018 | 132 | 0.280 |
Why?
|
| Mice, Knockout | 9 | 2023 | 1924 | 0.280 |
Why?
|
| Signal Transduction | 14 | 2018 | 3241 | 0.270 |
Why?
|
| DNA | 12 | 2015 | 1294 | 0.270 |
Why?
|
| Hamartoma | 2 | 2016 | 31 | 0.270 |
Why?
|
| Karyotyping | 10 | 2011 | 250 | 0.270 |
Why?
|
| Cerebrospinal Fluid Shunts | 2 | 2016 | 48 | 0.270 |
Why?
|
| Zebrafish | 7 | 2017 | 309 | 0.270 |
Why?
|
| Aortic Coarctation | 2 | 2017 | 35 | 0.270 |
Why?
|
| Exons | 15 | 2014 | 450 | 0.260 |
Why?
|
| Comparative Genomic Hybridization | 6 | 2020 | 39 | 0.260 |
Why?
|
| Hearing Loss | 2 | 2016 | 56 | 0.260 |
Why?
|
| Embryo, Mammalian | 5 | 2018 | 207 | 0.260 |
Why?
|
| Review Literature as Topic | 2 | 2020 | 21 | 0.260 |
Why?
|
| Arnold-Chiari Malformation | 2 | 2010 | 43 | 0.250 |
Why?
|
| Genitalia | 3 | 2005 | 21 | 0.250 |
Why?
|
| Functional Laterality | 4 | 2003 | 201 | 0.250 |
Why?
|
| Urogenital Abnormalities | 2 | 2021 | 19 | 0.250 |
Why?
|
| Repetitive Sequences, Amino Acid | 2 | 2003 | 12 | 0.250 |
Why?
|
| Microphthalmos | 2 | 2023 | 7 | 0.250 |
Why?
|
| Loss of Function Mutation | 3 | 2020 | 42 | 0.250 |
Why?
|
| Amniotic Band Syndrome | 1 | 2004 | 3 | 0.250 |
Why?
|
| Neocortex | 2 | 2023 | 95 | 0.250 |
Why?
|
| Focal Dermal Hypoplasia | 1 | 2004 | 1 | 0.250 |
Why?
|
| Encephalocele | 4 | 2013 | 24 | 0.240 |
Why?
|
| Optic Disk | 1 | 2004 | 13 | 0.240 |
Why?
|
| Language Development Disorders | 3 | 2020 | 24 | 0.240 |
Why?
|
| Atrophy | 5 | 2017 | 117 | 0.240 |
Why?
|
| Tomography, X-Ray Computed | 18 | 2020 | 2601 | 0.240 |
Why?
|
| High-Throughput Nucleotide Sequencing | 6 | 2016 | 456 | 0.240 |
Why?
|
| Homovanillic Acid | 3 | 1998 | 35 | 0.240 |
Why?
|
| Fatal Outcome | 9 | 2016 | 293 | 0.230 |
Why?
|
| Vacuolar Proton-Translocating ATPases | 1 | 2023 | 19 | 0.230 |
Why?
|
| Nuclear Proteins | 3 | 2017 | 696 | 0.230 |
Why?
|
| Mannosyltransferases | 3 | 2012 | 6 | 0.230 |
Why?
|
| Germ-Line Mutation | 6 | 2019 | 329 | 0.230 |
Why?
|
| Facial Neoplasms | 2 | 1995 | 25 | 0.230 |
Why?
|
| Fibroblasts | 7 | 2020 | 729 | 0.230 |
Why?
|
| Receptors, Retinoic Acid | 1 | 2023 | 45 | 0.230 |
Why?
|
| Chromosomes, Human, Pair 15 | 4 | 2009 | 63 | 0.230 |
Why?
|
| Sequence Homology, Amino Acid | 9 | 2014 | 416 | 0.230 |
Why?
|
| Frameshift Mutation | 5 | 2017 | 51 | 0.230 |
Why?
|
| Endosomal Sorting Complexes Required for Transport | 2 | 2013 | 15 | 0.230 |
Why?
|
| Clubfoot | 2 | 2013 | 3 | 0.230 |
Why?
|
| Nonmuscle Myosin Type IIB | 1 | 2022 | 4 | 0.220 |
Why?
|
| Pierre Robin Syndrome | 2 | 2013 | 13 | 0.220 |
Why?
|
| Leukoencephalopathies | 2 | 2020 | 15 | 0.220 |
Why?
|
| Databases, Genetic | 3 | 2015 | 260 | 0.220 |
Why?
|
| Chromosome Breakage | 5 | 2008 | 17 | 0.220 |
Why?
|
| Aneurysm | 2 | 2020 | 58 | 0.210 |
Why?
|
| Congenital Disorders of Glycosylation | 2 | 2019 | 4 | 0.210 |
Why?
|
| Sequence Analysis, DNA | 10 | 2017 | 853 | 0.210 |
Why?
|
| Pons | 3 | 2010 | 24 | 0.210 |
Why?
|
| Argonaute Proteins | 1 | 2021 | 10 | 0.210 |
Why?
|
| CREB-Binding Protein | 1 | 2021 | 16 | 0.210 |
Why?
|
| Nuclear Respiratory Factor 1 | 1 | 2021 | 6 | 0.210 |
Why?
|
| Polyradiculoneuropathy | 3 | 1990 | 8 | 0.210 |
Why?
|
| Databases, Factual | 2 | 2019 | 812 | 0.210 |
Why?
|
| E1A-Associated p300 Protein | 1 | 2021 | 11 | 0.210 |
Why?
|
| Muscular Diseases | 2 | 2011 | 63 | 0.210 |
Why?
|
| Cell Adhesion Molecules, Neuronal | 4 | 2009 | 29 | 0.210 |
Why?
|
| Craniosynostoses | 2 | 2000 | 77 | 0.210 |
Why?
|
| Drug Resistant Epilepsy | 1 | 2022 | 42 | 0.210 |
Why?
|
| Computational Biology | 4 | 2019 | 528 | 0.210 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 2 | 2014 | 379 | 0.210 |
Why?
|
| RNA-Binding Proteins | 2 | 2016 | 246 | 0.210 |
Why?
|
| Cysts | 1 | 2022 | 104 | 0.200 |
Why?
|
| Optic Nerve | 3 | 1996 | 35 | 0.200 |
Why?
|
| Apoptosis | 5 | 2018 | 1683 | 0.200 |
Why?
|
| Cleft Palate | 2 | 1999 | 25 | 0.200 |
Why?
|
| Prognosis | 7 | 2023 | 3675 | 0.200 |
Why?
|
| Hedgehog Proteins | 2 | 2022 | 93 | 0.200 |
Why?
|
| Chromosomes, Human, Pair 19 | 3 | 2010 | 59 | 0.200 |
Why?
|
| Embryonic Stem Cells | 1 | 2021 | 78 | 0.200 |
Why?
|
| Consensus | 2 | 2020 | 335 | 0.200 |
Why?
|
| Parkinsonian Disorders | 3 | 2007 | 21 | 0.200 |
Why?
|
| Repressor Proteins | 2 | 2017 | 403 | 0.200 |
Why?
|
| Acrocallosal Syndrome | 2 | 2011 | 2 | 0.200 |
Why?
|
| Stem Cells | 3 | 2019 | 351 | 0.200 |
Why?
|
| Awards and Prizes | 1 | 2021 | 36 | 0.200 |
Why?
|
| RNA, Messenger | 6 | 2021 | 1981 | 0.190 |
Why?
|
| Bladder Exstrophy | 1 | 2020 | 10 | 0.190 |
Why?
|
| Cloaca | 1 | 2020 | 4 | 0.190 |
Why?
|
| Microtubules | 2 | 2018 | 119 | 0.190 |
Why?
|
| Anus, Imperforate | 1 | 2020 | 11 | 0.190 |
Why?
|
| Twin Studies as Topic | 1 | 2020 | 19 | 0.190 |
Why?
|
| 46, XX Disorders of Sex Development | 1 | 2020 | 9 | 0.190 |
Why?
|
| Tracheoesophageal Fistula | 1 | 2020 | 11 | 0.190 |
Why?
|
| Mullerian Ducts | 1 | 2020 | 17 | 0.190 |
Why?
|
| Esophageal Atresia | 1 | 2020 | 13 | 0.190 |
Why?
|
| Myofibromatosis | 1 | 2020 | 3 | 0.190 |
Why?
|
| Hernia, Umbilical | 1 | 2020 | 17 | 0.190 |
Why?
|
| Nevus, Pigmented | 2 | 1991 | 49 | 0.190 |
Why?
|
| Follow-Up Studies | 7 | 2018 | 3636 | 0.190 |
Why?
|
| Delphi Technique | 1 | 2020 | 80 | 0.190 |
Why?
|
| Guanylate Kinases | 2 | 2011 | 12 | 0.190 |
Why?
|
| Organ Size | 4 | 2018 | 364 | 0.190 |
Why?
|
| Nystagmus, Pathologic | 3 | 2013 | 33 | 0.190 |
Why?
|
| Internationality | 1 | 2020 | 69 | 0.190 |
Why?
|
| Mutant Proteins | 3 | 2015 | 94 | 0.190 |
Why?
|
| Cerebral Angiography | 2 | 2018 | 196 | 0.190 |
Why?
|
| Electroencephalography | 9 | 2020 | 709 | 0.190 |
Why?
|
| Genetic Diseases, Inborn | 1 | 2021 | 101 | 0.190 |
Why?
|
| DNA-Binding Proteins | 4 | 2007 | 1208 | 0.180 |
Why?
|
| Imatinib Mesylate | 1 | 2020 | 126 | 0.180 |
Why?
|
| Chromosome Duplication | 1 | 2019 | 8 | 0.180 |
Why?
|
| Trans-Activators | 2 | 2020 | 429 | 0.180 |
Why?
|
| Amino Acids | 2 | 2021 | 252 | 0.180 |
Why?
|
| Magnetic Resonance Angiography | 3 | 2018 | 262 | 0.180 |
Why?
|
| beta-Transducin Repeat-Containing Proteins | 1 | 2019 | 5 | 0.180 |
Why?
|
| Sphingomyelin Phosphodiesterase | 1 | 2019 | 21 | 0.180 |
Why?
|
| Recurrence | 2 | 2020 | 1139 | 0.180 |
Why?
|
| WD40 Repeats | 1 | 2019 | 1 | 0.180 |
Why?
|
| Skull | 6 | 2006 | 249 | 0.180 |
Why?
|
| Wnt1 Protein | 2 | 2017 | 24 | 0.180 |
Why?
|
| DEAD-box RNA Helicases | 1 | 2020 | 62 | 0.180 |
Why?
|
| Immune Evasion | 1 | 2019 | 33 | 0.180 |
Why?
|
| Uridine Diphosphate Galactose | 1 | 2019 | 3 | 0.180 |
Why?
|
| Body Dysmorphic Disorders | 1 | 2019 | 12 | 0.180 |
Why?
|
| Extracellular Matrix Proteins | 3 | 2007 | 123 | 0.180 |
Why?
|
| Zygote | 1 | 2019 | 40 | 0.180 |
Why?
|
| Frontal Bone | 2 | 1998 | 16 | 0.170 |
Why?
|
| Serine Endopeptidases | 3 | 2007 | 145 | 0.170 |
Why?
|
| Skin Pigmentation | 1 | 2019 | 40 | 0.170 |
Why?
|
| History, 20th Century | 1 | 2020 | 312 | 0.170 |
Why?
|
| Cell-Free Nucleic Acids | 1 | 2020 | 71 | 0.170 |
Why?
|
| Peripheral Nervous System Diseases | 2 | 2000 | 85 | 0.170 |
Why?
|
| Oncogene Proteins, Fusion | 1 | 2020 | 128 | 0.170 |
Why?
|
| Migraine with Aura | 1 | 2019 | 4 | 0.170 |
Why?
|
| Astrocytes | 2 | 2016 | 139 | 0.170 |
Why?
|
| Parkinson Disease, Secondary | 1 | 1999 | 4 | 0.170 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 1 | 2021 | 183 | 0.170 |
Why?
|
| Monosaccharide Transport Proteins | 1 | 2019 | 73 | 0.170 |
Why?
|
| Risk Assessment | 2 | 2018 | 2261 | 0.170 |
Why?
|
| Amino Acid Substitution | 5 | 2014 | 339 | 0.170 |
Why?
|
| Methyl-CpG-Binding Protein 2 | 2 | 2016 | 16 | 0.170 |
Why?
|
| rhoA GTP-Binding Protein | 1 | 2019 | 83 | 0.170 |
Why?
|
| NFI Transcription Factors | 1 | 2018 | 7 | 0.170 |
Why?
|
| Centrosome | 2 | 2020 | 22 | 0.170 |
Why?
|
| Disease Models, Animal | 9 | 2018 | 2232 | 0.170 |
Why?
|
| Sex Chromosome Aberrations | 4 | 2001 | 19 | 0.170 |
Why?
|
| Lymphatic Vessels | 1 | 2019 | 68 | 0.170 |
Why?
|
| Dosage Compensation, Genetic | 6 | 2004 | 17 | 0.170 |
Why?
|
| alpha Catenin | 1 | 2018 | 7 | 0.170 |
Why?
|
| T-Box Domain Proteins | 1 | 2020 | 118 | 0.170 |
Why?
|
| Transcription Factor TFIID | 1 | 2018 | 3 | 0.170 |
Why?
|
| Genetic Carrier Screening | 4 | 2009 | 60 | 0.170 |
Why?
|
| Paraparesis, Spastic | 1 | 2018 | 1 | 0.170 |
Why?
|
| Interferon-Induced Helicase, IFIH1 | 1 | 2018 | 10 | 0.170 |
Why?
|
| Genomics | 2 | 2021 | 720 | 0.170 |
Why?
|
| Actin-Related Protein 2-3 Complex | 1 | 2018 | 20 | 0.170 |
Why?
|
| Spinocerebellar Ataxias | 1 | 1999 | 73 | 0.170 |
Why?
|
| Genome, Human | 6 | 2018 | 756 | 0.160 |
Why?
|
| rab GTP-Binding Proteins | 2 | 2011 | 26 | 0.160 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2019 | 165 | 0.160 |
Why?
|
| Intracranial Aneurysm | 1 | 2019 | 158 | 0.160 |
Why?
|
| Eye Proteins | 2 | 2009 | 128 | 0.160 |
Why?
|
| Receptors, G-Protein-Coupled | 3 | 2018 | 115 | 0.160 |
Why?
|
| Nose | 1 | 1998 | 94 | 0.160 |
Why?
|
| Bone Diseases, Developmental | 1 | 2017 | 11 | 0.160 |
Why?
|
| Severity of Illness Index | 7 | 2019 | 1801 | 0.160 |
Why?
|
| Periaqueductal Gray | 1 | 1997 | 10 | 0.160 |
Why?
|
| Sex Factors | 4 | 2009 | 1054 | 0.160 |
Why?
|
| Rats | 4 | 2018 | 3990 | 0.160 |
Why?
|
| Ciliopathies | 1 | 2017 | 1 | 0.160 |
Why?
|
| Armadillo Domain Proteins | 1 | 2017 | 3 | 0.160 |
Why?
|
| Basal Bodies | 1 | 2017 | 2 | 0.160 |
Why?
|
| Pituitary Gland | 1 | 2017 | 117 | 0.150 |
Why?
|
| Founder Effect | 4 | 2011 | 104 | 0.150 |
Why?
|
| Mice, Inbred C57BL | 7 | 2020 | 3092 | 0.150 |
Why?
|
| Polymerase Chain Reaction | 8 | 2015 | 927 | 0.150 |
Why?
|
| Cell Adhesion Molecules | 1 | 2018 | 163 | 0.150 |
Why?
|
| Connective Tissue | 1 | 1997 | 23 | 0.150 |
Why?
|
| Haplotypes | 7 | 2011 | 642 | 0.150 |
Why?
|
| Genetic Markers | 7 | 2007 | 476 | 0.150 |
Why?
|
| Exonucleases | 1 | 2017 | 8 | 0.150 |
Why?
|
| Gene Expression | 5 | 2016 | 1284 | 0.150 |
Why?
|
| Neural Stem Cells | 2 | 2014 | 58 | 0.150 |
Why?
|
| Middle Aged | 24 | 2020 | 25017 | 0.150 |
Why?
|
| CRADD Signaling Adaptor Protein | 1 | 2016 | 1 | 0.150 |
Why?
|
| Chorea | 2 | 1993 | 13 | 0.150 |
Why?
|
| Prospective Studies | 4 | 2020 | 4212 | 0.150 |
Why?
|
| Caspase 2 | 1 | 2016 | 9 | 0.150 |
Why?
|
| Protein Subunits | 1 | 2017 | 122 | 0.150 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 4 | 2012 | 689 | 0.150 |
Why?
|
| RNA, Small Nuclear | 1 | 2017 | 32 | 0.150 |
Why?
|
| Hirschsprung Disease | 1 | 2016 | 11 | 0.150 |
Why?
|
| Cerebrum | 1 | 2016 | 15 | 0.150 |
Why?
|
| Gene Expression Regulation | 4 | 2019 | 1920 | 0.150 |
Why?
|
| Face | 9 | 2019 | 114 | 0.150 |
Why?
|
| Cognition | 4 | 2020 | 570 | 0.150 |
Why?
|
| Vascular Diseases | 2 | 2004 | 121 | 0.150 |
Why?
|
| Catenins | 1 | 2016 | 11 | 0.150 |
Why?
|
| Rhabdoid Tumor | 1 | 2016 | 19 | 0.150 |
Why?
|
| Cephalometry | 2 | 2006 | 50 | 0.140 |
Why?
|
| Protein Kinase C-epsilon | 1 | 2016 | 22 | 0.140 |
Why?
|
| Hand Deformities, Congenital | 2 | 2016 | 15 | 0.140 |
Why?
|
| Smoothened Receptor | 1 | 2016 | 6 | 0.140 |
Why?
|
| Tuberous Sclerosis | 3 | 2008 | 28 | 0.140 |
Why?
|
| History, Ancient | 2 | 2006 | 74 | 0.140 |
Why?
|
| Mechanistic Target of Rapamycin Complex 1 | 1 | 2016 | 29 | 0.140 |
Why?
|
| Organogenesis | 1 | 2016 | 41 | 0.140 |
Why?
|
| Cysteine Endopeptidases | 1 | 2016 | 87 | 0.140 |
Why?
|
| Teratoma | 1 | 2016 | 50 | 0.140 |
Why?
|
| Exosome Multienzyme Ribonuclease Complex | 1 | 2016 | 4 | 0.140 |
Why?
|
| Synaptic Transmission | 3 | 2011 | 222 | 0.140 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 1 | 1 | 2016 | 19 | 0.140 |
Why?
|
| Aging, Premature | 1 | 2016 | 7 | 0.140 |
Why?
|
| Heart | 1 | 2019 | 539 | 0.140 |
Why?
|
| Osteogenesis Imperfecta | 1 | 2015 | 4 | 0.140 |
Why?
|
| N-Acetylglucosaminyltransferases | 3 | 2006 | 13 | 0.140 |
Why?
|
| Mandibulofacial Dysostosis | 1 | 2015 | 5 | 0.140 |
Why?
|
| Ribonucleoprotein, U5 Small Nuclear | 1 | 2015 | 9 | 0.140 |
Why?
|
| Filamins | 6 | 2006 | 19 | 0.140 |
Why?
|
| Retinitis Pigmentosa | 1 | 2016 | 35 | 0.140 |
Why?
|
| Telangiectasis | 2 | 2013 | 6 | 0.140 |
Why?
|
| Immunohistochemistry | 7 | 2016 | 1753 | 0.140 |
Why?
|
| Zebrafish Proteins | 1 | 2017 | 144 | 0.140 |
Why?
|
| Enhancer of Zeste Homolog 2 Protein | 1 | 2016 | 35 | 0.140 |
Why?
|
| Peptide Elongation Factors | 1 | 2015 | 28 | 0.140 |
Why?
|
| Pseudopseudohypoparathyroidism | 1 | 1995 | 1 | 0.140 |
Why?
|
| Fibrous Dysplasia, Polyostotic | 1 | 1995 | 2 | 0.140 |
Why?
|
| DNA Primers | 7 | 2015 | 543 | 0.140 |
Why?
|
| Multiprotein Complexes | 1 | 2016 | 95 | 0.130 |
Why?
|
| Mental Retardation, X-Linked | 2 | 2013 | 21 | 0.130 |
Why?
|
| Muscle, Skeletal | 5 | 2013 | 449 | 0.130 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2016 | 179 | 0.130 |
Why?
|
| ras Proteins | 1 | 2016 | 128 | 0.130 |
Why?
|
| Catastrophic Illness | 1 | 2015 | 1 | 0.130 |
Why?
|
| Codon, Nonsense | 3 | 2018 | 41 | 0.130 |
Why?
|
| Klippel-Trenaunay-Weber Syndrome | 1 | 2015 | 5 | 0.130 |
Why?
|
| Language | 1 | 2017 | 151 | 0.130 |
Why?
|
| Sebaceous Glands | 1 | 1995 | 28 | 0.130 |
Why?
|
| Nevus | 1 | 1995 | 15 | 0.130 |
Why?
|
| Cell Line | 8 | 2015 | 2468 | 0.130 |
Why?
|
| Optic Lobe, Nonmammalian | 1 | 2014 | 1 | 0.130 |
Why?
|
| Congenital Hypothyroidism | 1 | 2016 | 79 | 0.130 |
Why?
|
| Family | 5 | 2015 | 311 | 0.130 |
Why?
|
| Transfection | 5 | 2018 | 896 | 0.130 |
Why?
|
| Limb Deformities, Congenital | 2 | 2012 | 21 | 0.130 |
Why?
|
| Cerebellar Vermis | 3 | 2020 | 5 | 0.130 |
Why?
|
| Hypothalamus | 1 | 2015 | 79 | 0.130 |
Why?
|
| Retinal Dysplasia | 1 | 2014 | 3 | 0.130 |
Why?
|
| Prosthesis Failure | 1 | 2015 | 111 | 0.130 |
Why?
|
| Cerebral Small Vessel Diseases | 1 | 2014 | 7 | 0.130 |
Why?
|
| Mitosis | 3 | 2019 | 153 | 0.130 |
Why?
|
| Transcription, Genetic | 2 | 2018 | 1135 | 0.130 |
Why?
|
| Chromosomes, Human, 16-18 | 5 | 1986 | 26 | 0.120 |
Why?
|
| Glycine | 2 | 2018 | 92 | 0.120 |
Why?
|
| Spindle Apparatus | 2 | 2014 | 65 | 0.120 |
Why?
|
| Kinetochores | 1 | 2014 | 7 | 0.120 |
Why?
|
| Centromere | 1 | 2014 | 26 | 0.120 |
Why?
|
| Knowledge Bases | 1 | 2014 | 14 | 0.120 |
Why?
|
| Osteochondrodysplasias | 1 | 2014 | 11 | 0.120 |
Why?
|
| Lod Score | 6 | 2009 | 152 | 0.120 |
Why?
|
| Motor Activity | 1 | 2017 | 327 | 0.120 |
Why?
|
| Chromosomes, Artificial, Bacterial | 3 | 2008 | 30 | 0.120 |
Why?
|
| Neurodegenerative Diseases | 2 | 2017 | 44 | 0.120 |
Why?
|
| Optic Atrophy | 2 | 2011 | 5 | 0.120 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2016 | 427 | 0.120 |
Why?
|
| Drosophila melanogaster | 2 | 2019 | 599 | 0.120 |
Why?
|
| Membrane Glycoproteins | 3 | 2013 | 428 | 0.120 |
Why?
|
| Malformations of Cortical Development, Group II | 1 | 2013 | 1 | 0.120 |
Why?
|
| Adenosine Triphosphatases | 1 | 2014 | 153 | 0.120 |
Why?
|
| alpha Karyopherins | 1 | 2013 | 10 | 0.120 |
Why?
|
| Stereotypic Movement Disorder | 1 | 2013 | 5 | 0.120 |
Why?
|
| Fetal Growth Retardation | 1 | 2014 | 66 | 0.120 |
Why?
|
| Disease | 1 | 2014 | 90 | 0.120 |
Why?
|
| Skin Diseases, Vascular | 1 | 2013 | 3 | 0.120 |
Why?
|
| Chromosomal Proteins, Non-Histone | 1 | 2014 | 58 | 0.120 |
Why?
|
| Adaptor Protein Complex sigma Subunits | 1 | 2013 | 1 | 0.120 |
Why?
|
| Segmental Duplications, Genomic | 1 | 2013 | 4 | 0.120 |
Why?
|
| Basal Ganglia Diseases | 1 | 2013 | 9 | 0.120 |
Why?
|
| Vestibular Diseases | 1 | 2013 | 27 | 0.120 |
Why?
|
| DNA-Activated Protein Kinase | 1 | 2013 | 16 | 0.120 |
Why?
|
| Severe Combined Immunodeficiency | 1 | 2013 | 17 | 0.120 |
Why?
|
| Head Movements | 1 | 2013 | 39 | 0.120 |
Why?
|
| Genome-Wide Association Study | 7 | 2016 | 1621 | 0.120 |
Why?
|
| Tyrosine 3-Monooxygenase | 2 | 2003 | 44 | 0.120 |
Why?
|
| Radiography | 6 | 2011 | 813 | 0.120 |
Why?
|
| Hair | 1 | 2013 | 56 | 0.110 |
Why?
|
| Quadriplegia | 2 | 2011 | 22 | 0.110 |
Why?
|
| Genes, Overlapping | 1 | 2013 | 4 | 0.110 |
Why?
|
| Chromosomes, Human, Pair 5 | 2 | 2010 | 109 | 0.110 |
Why?
|
| RNA Interference | 1 | 2014 | 369 | 0.110 |
Why?
|
| N-Acetylgalactosaminyltransferases | 1 | 2013 | 12 | 0.110 |
Why?
|
| Practice Guidelines as Topic | 1 | 2020 | 1034 | 0.110 |
Why?
|
| Hyperkinesis | 1 | 2013 | 15 | 0.110 |
Why?
|
| Incidence | 3 | 2010 | 1577 | 0.110 |
Why?
|
| Orofaciodigital Syndromes | 1 | 2012 | 2 | 0.110 |
Why?
|
| Lymphocytes | 5 | 2014 | 464 | 0.110 |
Why?
|
| Cerebellar Cortex | 1 | 2012 | 14 | 0.110 |
Why?
|
| Cell Proliferation | 3 | 2014 | 1578 | 0.110 |
Why?
|
| Intestines | 1 | 2016 | 411 | 0.110 |
Why?
|
| Ubiquitin Thiolesterase | 1 | 2013 | 63 | 0.110 |
Why?
|
| Mitogen-Activated Protein Kinase 7 | 1 | 2012 | 21 | 0.110 |
Why?
|
| Fossils | 2 | 2006 | 337 | 0.110 |
Why?
|
| Diencephalon | 1 | 2012 | 6 | 0.110 |
Why?
|
| Cataract | 3 | 2011 | 86 | 0.110 |
Why?
|
| Glycosylation | 5 | 2013 | 129 | 0.110 |
Why?
|
| Neurologic Examination | 4 | 1996 | 118 | 0.110 |
Why?
|
| Mannose | 1 | 2012 | 8 | 0.110 |
Why?
|
| Nucleotidyltransferases | 1 | 2012 | 29 | 0.110 |
Why?
|
| Cerebellar Ataxia | 2 | 2006 | 20 | 0.110 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2012 | 104 | 0.110 |
Why?
|
| Drosophila | 3 | 2018 | 498 | 0.110 |
Why?
|
| Esophagus | 1 | 2012 | 102 | 0.100 |
Why?
|
| Muscle Spasticity | 2 | 2010 | 9 | 0.100 |
Why?
|
| Spine | 1 | 2012 | 102 | 0.100 |
Why?
|
| Anal Canal | 1 | 2012 | 89 | 0.100 |
Why?
|
| Risk Factors | 4 | 2018 | 5417 | 0.100 |
Why?
|
| Gyrus Cinguli | 2 | 2010 | 45 | 0.100 |
Why?
|
| Cell Death | 2 | 2018 | 256 | 0.100 |
Why?
|
| Molecular Biology | 1 | 2012 | 89 | 0.100 |
Why?
|
| Body Mass Index | 1 | 2015 | 770 | 0.100 |
Why?
|
| Collagen Type IV | 1 | 2011 | 24 | 0.100 |
Why?
|
| Chromosome Banding | 10 | 2007 | 74 | 0.100 |
Why?
|
| Facial Expression | 2 | 1991 | 51 | 0.100 |
Why?
|
| Trachea | 1 | 2012 | 293 | 0.100 |
Why?
|
| Biological Science Disciplines | 1 | 2011 | 12 | 0.100 |
Why?
|
| Skin Diseases | 1 | 2013 | 166 | 0.100 |
Why?
|
| Facial Asymmetry | 1 | 1991 | 12 | 0.100 |
Why?
|
| Rett Syndrome | 1 | 2011 | 19 | 0.100 |
Why?
|
| Ependymoglial Cells | 2 | 2023 | 5 | 0.100 |
Why?
|
| Chromosomes, Human, Pair 14 | 1 | 2011 | 49 | 0.100 |
Why?
|
| Arginine-tRNA Ligase | 1 | 2010 | 3 | 0.100 |
Why?
|
| Basal Ganglia | 2 | 2009 | 42 | 0.100 |
Why?
|
| Paresis | 1 | 2010 | 15 | 0.100 |
Why?
|
| Cricetulus | 2 | 2022 | 126 | 0.100 |
Why?
|
| Mediator Complex | 1 | 2010 | 12 | 0.100 |
Why?
|
| United States | 2 | 2020 | 6665 | 0.100 |
Why?
|
| Transcriptome | 3 | 2021 | 580 | 0.100 |
Why?
|
| Ultrasonography, Prenatal | 3 | 2017 | 152 | 0.100 |
Why?
|
| Cell Differentiation | 4 | 2021 | 1458 | 0.100 |
Why?
|
| 3-Oxo-5-alpha-Steroid 4-Dehydrogenase | 1 | 2010 | 9 | 0.100 |
Why?
|
| Cornea | 3 | 2011 | 69 | 0.100 |
Why?
|
| Genes, X-Linked | 1 | 2010 | 37 | 0.090 |
Why?
|
| Case-Control Studies | 6 | 2013 | 1804 | 0.090 |
Why?
|
| Sequence Alignment | 4 | 2012 | 351 | 0.090 |
Why?
|
| Poliovirus Vaccine, Oral | 1 | 1990 | 4 | 0.090 |
Why?
|
| Edema | 1 | 2010 | 71 | 0.090 |
Why?
|
| Morphogenesis | 1 | 2012 | 192 | 0.090 |
Why?
|
| Body Patterning | 2 | 2009 | 209 | 0.090 |
Why?
|
| Haemophilus Vaccines | 1 | 1989 | 5 | 0.090 |
Why?
|
| Haemophilus Infections | 1 | 1989 | 6 | 0.090 |
Why?
|
| Musculoskeletal Abnormalities | 2 | 2011 | 9 | 0.090 |
Why?
|
| Neural Tube | 1 | 2009 | 9 | 0.090 |
Why?
|
| Sex Distribution | 1 | 2010 | 173 | 0.090 |
Why?
|
| Bacterial Vaccines | 1 | 1989 | 41 | 0.090 |
Why?
|
| Polysaccharides, Bacterial | 1 | 1989 | 31 | 0.090 |
Why?
|
| Phosphoproteins | 2 | 2018 | 254 | 0.090 |
Why?
|
| Amino Acid Metabolism, Inborn Errors | 1 | 1989 | 11 | 0.090 |
Why?
|
| Sequence Homology | 2 | 2019 | 28 | 0.090 |
Why?
|
| Retinal Degeneration | 2 | 2008 | 28 | 0.090 |
Why?
|
| Image Processing, Computer-Assisted | 2 | 2012 | 1204 | 0.090 |
Why?
|
| Ataxia | 1 | 2009 | 37 | 0.090 |
Why?
|
| Nucleic Acid Hybridization | 6 | 2008 | 245 | 0.090 |
Why?
|
| Tight Junctions | 1 | 2010 | 149 | 0.090 |
Why?
|
| PAX2 Transcription Factor | 3 | 1999 | 6 | 0.090 |
Why?
|
| Advisory Committees | 1 | 2009 | 90 | 0.090 |
Why?
|
| Nerve Net | 1 | 2013 | 366 | 0.090 |
Why?
|
| Lymphedema | 1 | 2010 | 77 | 0.090 |
Why?
|
| Biomarkers | 4 | 2016 | 1718 | 0.090 |
Why?
|
| Cisterna Magna | 2 | 2009 | 10 | 0.090 |
Why?
|
| Data Collection | 1 | 2010 | 372 | 0.080 |
Why?
|
| Gene Frequency | 5 | 2015 | 677 | 0.080 |
Why?
|
| Cadherins | 1 | 2009 | 151 | 0.080 |
Why?
|
| Cell Division | 3 | 2014 | 696 | 0.080 |
Why?
|
| Cutis Laxa | 1 | 2008 | 4 | 0.080 |
Why?
|
| ADP-Ribosylation Factors | 1 | 2008 | 9 | 0.080 |
Why?
|
| Nervous System Diseases | 3 | 2015 | 151 | 0.080 |
Why?
|
| Neurology | 1 | 2009 | 70 | 0.080 |
Why?
|
| Gene Regulatory Networks | 1 | 2011 | 296 | 0.080 |
Why?
|
| Treatment Outcome | 3 | 2016 | 7990 | 0.080 |
Why?
|
| Chromosomes, Human, Pair 21 | 1 | 2008 | 54 | 0.080 |
Why?
|
| Chromosomes, Human, Pair 4 | 1 | 2008 | 48 | 0.080 |
Why?
|
| Aneuploidy | 1 | 2008 | 55 | 0.080 |
Why?
|
| Phosphorylation | 3 | 2016 | 1106 | 0.080 |
Why?
|
| Glaucoma | 1 | 2008 | 30 | 0.080 |
Why?
|
| Muscle Hypotonia | 2 | 2021 | 45 | 0.080 |
Why?
|
| Occipital Bone | 1 | 2008 | 18 | 0.080 |
Why?
|
| Gastroesophageal Reflux | 1 | 2010 | 117 | 0.080 |
Why?
|
| RNA Splicing | 3 | 2019 | 142 | 0.080 |
Why?
|
| Genetic Heterogeneity | 1 | 2008 | 62 | 0.080 |
Why?
|
| Introns | 5 | 2012 | 289 | 0.080 |
Why?
|
| Mutagenesis, Site-Directed | 3 | 2017 | 279 | 0.080 |
Why?
|
| Macaca nemestrina | 2 | 2018 | 18 | 0.080 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 2010 | 276 | 0.080 |
Why?
|
| Eye Neoplasms | 1 | 1987 | 27 | 0.080 |
Why?
|
| Cell Line, Tumor | 3 | 2020 | 2426 | 0.080 |
Why?
|
| Antigens, Neoplasm | 1 | 2009 | 325 | 0.080 |
Why?
|
| Methoxyhydroxyphenylglycol | 2 | 1998 | 18 | 0.080 |
Why?
|
| Haploidy | 1 | 2007 | 31 | 0.080 |
Why?
|
| Hydroxyindoleacetic Acid | 2 | 1998 | 27 | 0.080 |
Why?
|
| Alanine | 1 | 2007 | 85 | 0.080 |
Why?
|
| Protein Binding | 3 | 2021 | 1456 | 0.080 |
Why?
|
| Velopharyngeal Insufficiency | 1 | 2006 | 3 | 0.070 |
Why?
|
| Hippocampus | 2 | 2020 | 442 | 0.070 |
Why?
|
| Medulla Oblongata | 1 | 2007 | 89 | 0.070 |
Why?
|
| Immunoprecipitation | 2 | 2017 | 134 | 0.070 |
Why?
|
| Indonesia | 1 | 2006 | 11 | 0.070 |
Why?
|
| Zinc Fingers | 2 | 2004 | 56 | 0.070 |
Why?
|
| Cell Lineage | 2 | 2019 | 273 | 0.070 |
Why?
|
| Archaeology | 1 | 2006 | 14 | 0.070 |
Why?
|
| Peptides | 2 | 2003 | 639 | 0.070 |
Why?
|
| Liver Cirrhosis | 1 | 2009 | 297 | 0.070 |
Why?
|
| Evidence-Based Medicine | 1 | 2009 | 429 | 0.070 |
Why?
|
| Neuroglia | 2 | 2013 | 104 | 0.070 |
Why?
|
| Glutamic Acid | 2 | 2018 | 152 | 0.070 |
Why?
|
| Hemangioma, Cavernous | 1 | 1987 | 69 | 0.070 |
Why?
|
| Polymorphism, Genetic | 4 | 2006 | 819 | 0.070 |
Why?
|
| Regulatory Elements, Transcriptional | 1 | 2006 | 45 | 0.070 |
Why?
|
| Enzyme Inhibitors | 2 | 2015 | 639 | 0.070 |
Why?
|
| Models, Anatomic | 1 | 2006 | 91 | 0.070 |
Why?
|
| Clinical Enzyme Tests | 1 | 2006 | 7 | 0.070 |
Why?
|
| Skin | 3 | 2017 | 554 | 0.070 |
Why?
|
| RNA, Small Interfering | 3 | 2015 | 547 | 0.070 |
Why?
|
| Glutathione Transferase | 2 | 2003 | 111 | 0.070 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2006 | 122 | 0.070 |
Why?
|
| Retinal Diseases | 1 | 1987 | 90 | 0.070 |
Why?
|
| Time Factors | 4 | 1998 | 5209 | 0.070 |
Why?
|
| Skin Neoplasms | 1 | 1991 | 541 | 0.070 |
Why?
|
| Spliceosomes | 2 | 2017 | 45 | 0.070 |
Why?
|
| Neoplasm Proteins | 1 | 2009 | 532 | 0.070 |
Why?
|
| Prevalence | 1 | 2010 | 1239 | 0.070 |
Why?
|
| Chromosomes, Human, 6-12 and X | 1 | 1985 | 23 | 0.070 |
Why?
|
| Disease Progression | 3 | 2017 | 1531 | 0.070 |
Why?
|
| Gestational Age | 2 | 2018 | 311 | 0.070 |
Why?
|
| Testis | 2 | 2004 | 152 | 0.070 |
Why?
|
| Microsatellite Repeats | 4 | 2007 | 144 | 0.070 |
Why?
|
| Parietal Lobe | 2 | 2004 | 117 | 0.070 |
Why?
|
| Electromyography | 2 | 1996 | 183 | 0.070 |
Why?
|
| Sex Characteristics | 3 | 2002 | 319 | 0.070 |
Why?
|
| Dopamine | 2 | 1998 | 275 | 0.070 |
Why?
|
| Real-Time Polymerase Chain Reaction | 2 | 2020 | 273 | 0.070 |
Why?
|
| DNA Damage | 1 | 2007 | 366 | 0.070 |
Why?
|
| Aged | 10 | 2018 | 18402 | 0.060 |
Why?
|
| Telomere | 2 | 2003 | 108 | 0.060 |
Why?
|
| Endoplasmic Reticulum | 2 | 2019 | 250 | 0.060 |
Why?
|
| Hypertrophy | 1 | 2004 | 62 | 0.060 |
Why?
|
| Saccharomyces cerevisiae | 2 | 2023 | 434 | 0.060 |
Why?
|
| Cell Cycle | 2 | 2019 | 502 | 0.060 |
Why?
|
| Ultrasonography | 3 | 2009 | 695 | 0.060 |
Why?
|
| Intestinal Atresia | 1 | 2004 | 4 | 0.060 |
Why?
|
| Gonadal Dysgenesis, 46,XY | 1 | 2004 | 4 | 0.060 |
Why?
|
| Disorders of Sex Development | 1 | 2004 | 18 | 0.060 |
Why?
|
| Stiff-Person Syndrome | 1 | 2004 | 1 | 0.060 |
Why?
|
| Toes | 1 | 2004 | 14 | 0.060 |
Why?
|
| alpha-Mannosidase | 1 | 2003 | 1 | 0.060 |
Why?
|
| Protein Conformation | 3 | 2015 | 881 | 0.060 |
Why?
|
| Polymorphism, Restriction Fragment Length | 3 | 1993 | 147 | 0.060 |
Why?
|
| Receptors, Glycine | 1 | 2004 | 10 | 0.060 |
Why?
|
| Receptors, Metabotropic Glutamate | 1 | 2004 | 52 | 0.060 |
Why?
|
| Lateral Ventricles | 1 | 2003 | 12 | 0.060 |
Why?
|
| Jejunum | 1 | 2004 | 79 | 0.060 |
Why?
|
| Alternative Splicing | 2 | 2017 | 201 | 0.060 |
Why?
|
| Hypogonadism | 2 | 2011 | 37 | 0.060 |
Why?
|
| Biopsy | 2 | 2019 | 1162 | 0.060 |
Why?
|
| Crossing Over, Genetic | 1 | 2003 | 33 | 0.060 |
Why?
|
| Retinoids | 1 | 2023 | 17 | 0.060 |
Why?
|
| Imaging, Three-Dimensional | 2 | 2020 | 579 | 0.060 |
Why?
|
| Chromosomes, Human, Pair 9 | 3 | 2005 | 86 | 0.060 |
Why?
|
| Genes | 2 | 2008 | 305 | 0.060 |
Why?
|
| Diffuse Cerebral Sclerosis of Schilder | 2 | 1997 | 5 | 0.060 |
Why?
|
| HeLa Cells | 2 | 2017 | 498 | 0.060 |
Why?
|
| Birth Weight | 2 | 2007 | 145 | 0.060 |
Why?
|
| Bronchi | 1 | 2004 | 229 | 0.060 |
Why?
|
| Evolution, Molecular | 2 | 2006 | 813 | 0.060 |
Why?
|
| GTPase-Activating Proteins | 1 | 2003 | 65 | 0.060 |
Why?
|
| Cranial Fossa, Posterior | 1 | 2022 | 25 | 0.060 |
Why?
|
| Chi-Square Distribution | 3 | 2010 | 364 | 0.050 |
Why?
|
| Protein Structure, Tertiary | 2 | 2015 | 736 | 0.050 |
Why?
|
| KCNQ Potassium Channels | 1 | 2022 | 7 | 0.050 |
Why?
|
| Myosin Heavy Chains | 1 | 2022 | 88 | 0.050 |
Why?
|
| Protein Structure, Secondary | 2 | 2015 | 330 | 0.050 |
Why?
|
| Computer Simulation | 1 | 2006 | 1078 | 0.050 |
Why?
|
| Chromosome Segregation | 2 | 2014 | 32 | 0.050 |
Why?
|
| Adenosine Triphosphate | 1 | 2023 | 314 | 0.050 |
Why?
|
| Laser Capture Microdissection | 1 | 2021 | 20 | 0.050 |
Why?
|
| Amino Acid Motifs | 2 | 2015 | 116 | 0.050 |
Why?
|
| Eye Diseases, Hereditary | 1 | 2001 | 8 | 0.050 |
Why?
|
| Brain Neoplasms | 1 | 1987 | 763 | 0.050 |
Why?
|
| Regulatory Factor X Transcription Factors | 1 | 2021 | 11 | 0.050 |
Why?
|
| Cricetinae | 1 | 2022 | 560 | 0.050 |
Why?
|
| Extremities | 2 | 2007 | 165 | 0.050 |
Why?
|
| Hydrolases | 1 | 2021 | 28 | 0.050 |
Why?
|
| Disks Large Homolog 4 Protein | 1 | 2021 | 7 | 0.050 |
Why?
|
| COS Cells | 1 | 2021 | 166 | 0.050 |
Why?
|
| Protein Domains | 1 | 2021 | 128 | 0.050 |
Why?
|
| Models, Genetic | 2 | 2003 | 926 | 0.050 |
Why?
|
| Multiplex Polymerase Chain Reaction | 1 | 2020 | 33 | 0.050 |
Why?
|
| Cryptorchidism | 1 | 2000 | 11 | 0.050 |
Why?
|
| Cystic Fibrosis Transmembrane Conductance Regulator | 1 | 2021 | 57 | 0.050 |
Why?
|
| Transcriptional Activation | 1 | 2021 | 280 | 0.050 |
Why?
|
| Cell Count | 2 | 2014 | 195 | 0.050 |
Why?
|
| Gene Order | 2 | 2014 | 22 | 0.050 |
Why?
|
| Phospholipases A | 1 | 2000 | 45 | 0.050 |
Why?
|
| Aspirin | 1 | 2021 | 156 | 0.050 |
Why?
|
| Nonsense Mediated mRNA Decay | 1 | 2020 | 4 | 0.050 |
Why?
|
| Codon | 1 | 2020 | 124 | 0.050 |
Why?
|
| Diagnostic Tests, Routine | 1 | 2020 | 62 | 0.050 |
Why?
|
| Sotos Syndrome | 1 | 2019 | 1 | 0.050 |
Why?
|
| Basilar Artery | 1 | 2020 | 41 | 0.050 |
Why?
|
| Cystic Fibrosis | 1 | 2021 | 112 | 0.050 |
Why?
|
| Structure-Activity Relationship | 2 | 2015 | 408 | 0.050 |
Why?
|
| Spatio-Temporal Analysis | 1 | 2019 | 21 | 0.050 |
Why?
|
| Mice, Neurologic Mutants | 1 | 1999 | 18 | 0.050 |
Why?
|
| Proteomics | 1 | 2021 | 212 | 0.050 |
Why?
|
| Physostigmine | 1 | 1979 | 19 | 0.040 |
Why?
|
| Single-Cell Analysis | 1 | 2021 | 134 | 0.040 |
Why?
|
| Reye Syndrome | 1 | 1979 | 22 | 0.040 |
Why?
|
| DNA Repair | 2 | 2013 | 356 | 0.040 |
Why?
|
| Bromodeoxyuridine | 2 | 2014 | 57 | 0.040 |
Why?
|
| Virus Internalization | 1 | 2019 | 39 | 0.040 |
Why?
|
| Longitudinal Studies | 2 | 2016 | 1019 | 0.040 |
Why?
|
| Whole Genome Sequencing | 1 | 2020 | 76 | 0.040 |
Why?
|
| Ocular Motility Disorders | 2 | 2003 | 17 | 0.040 |
Why?
|
| RNA | 2 | 2020 | 560 | 0.040 |
Why?
|
| Gene Knockdown Techniques | 1 | 2020 | 236 | 0.040 |
Why?
|
| PAX6 Transcription Factor | 1 | 2018 | 10 | 0.040 |
Why?
|
| CHO Cells | 1 | 2019 | 187 | 0.040 |
Why?
|
| Hepatolenticular Degeneration | 1 | 1979 | 19 | 0.040 |
Why?
|
| Carotid Arteries | 1 | 2020 | 127 | 0.040 |
Why?
|
| Chromatin | 1 | 2021 | 380 | 0.040 |
Why?
|
| Sodium-Phosphate Cotransporter Proteins, Type III | 1 | 2018 | 1 | 0.040 |
Why?
|
| Pilot Projects | 1 | 2021 | 839 | 0.040 |
Why?
|
| Gain of Function Mutation | 1 | 2018 | 13 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-sis | 1 | 2018 | 27 | 0.040 |
Why?
|
| Blastocyst | 1 | 2018 | 34 | 0.040 |
Why?
|
| Mouse Embryonic Stem Cells | 1 | 2018 | 11 | 0.040 |
Why?
|
| Dysarthria | 1 | 1998 | 6 | 0.040 |
Why?
|
| In Situ Hybridization | 2 | 2010 | 307 | 0.040 |
Why?
|
| Receptors, Virus | 1 | 2018 | 74 | 0.040 |
Why?
|
| Antiparkinson Agents | 1 | 1998 | 15 | 0.040 |
Why?
|
| Gene Ontology | 1 | 2018 | 34 | 0.040 |
Why?
|
| RNA Polymerase II | 1 | 2018 | 55 | 0.040 |
Why?
|
| Cloning, Molecular | 2 | 2016 | 646 | 0.040 |
Why?
|
| N-Methylaspartate | 1 | 2018 | 51 | 0.040 |
Why?
|
| Virus Replication | 1 | 2019 | 319 | 0.040 |
Why?
|
| Excitatory Amino Acid Agonists | 1 | 2018 | 45 | 0.040 |
Why?
|
| Placenta | 1 | 2019 | 175 | 0.040 |
Why?
|
| DNA, Complementary | 4 | 2002 | 393 | 0.040 |
Why?
|
| Guidelines as Topic | 1 | 2019 | 162 | 0.040 |
Why?
|
| Protein Isoforms | 1 | 2019 | 270 | 0.040 |
Why?
|
| Finland | 2 | 2004 | 29 | 0.040 |
Why?
|
| Microscopy, Fluorescence | 2 | 2014 | 425 | 0.040 |
Why?
|
| Spinocerebellar Degenerations | 1 | 1997 | 18 | 0.040 |
Why?
|
| Zinc Finger Protein Gli3 | 1 | 2017 | 8 | 0.040 |
Why?
|
| Phosphatidylinositols | 1 | 2017 | 21 | 0.040 |
Why?
|
| Protein Aggregation, Pathological | 1 | 2017 | 7 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 3 | 2 | 2010 | 54 | 0.040 |
Why?
|
| Species Specificity | 1 | 2019 | 678 | 0.040 |
Why?
|
| Norepinephrine | 1 | 1998 | 167 | 0.040 |
Why?
|
| Pregnancy Outcome | 1 | 1999 | 247 | 0.040 |
Why?
|
| Mutagenesis | 1 | 2018 | 199 | 0.040 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2019 | 104 | 0.040 |
Why?
|
| Nerve Degeneration | 1 | 1997 | 83 | 0.040 |
Why?
|
| Physical Chromosome Mapping | 2 | 2009 | 27 | 0.040 |
Why?
|
| Valproic Acid | 1 | 1997 | 24 | 0.040 |
Why?
|
| Memantine | 1 | 2017 | 10 | 0.040 |
Why?
|
| Animals, Newborn | 1 | 2018 | 510 | 0.040 |
Why?
|
| Evoked Potentials, Visual | 1 | 1997 | 87 | 0.040 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2017 | 93 | 0.040 |
Why?
|
| Zinc Finger E-box Binding Homeobox 2 | 1 | 2016 | 2 | 0.040 |
Why?
|
| Purkinje Cells | 1 | 1997 | 80 | 0.040 |
Why?
|
| Ring Chromosomes | 1 | 2016 | 1 | 0.040 |
Why?
|
| Liver Failure, Acute | 1 | 1997 | 38 | 0.040 |
Why?
|
| Language Tests | 1 | 2017 | 37 | 0.040 |
Why?
|
| SMARCB1 Protein | 1 | 2016 | 13 | 0.040 |
Why?
|
| Echoencephalography | 1 | 2016 | 12 | 0.040 |
Why?
|
| Disease Management | 1 | 2019 | 327 | 0.040 |
Why?
|
| Patch-Clamp Techniques | 1 | 2018 | 396 | 0.040 |
Why?
|
| Contact Inhibition | 1 | 2016 | 3 | 0.040 |
Why?
|
| Inositol | 1 | 2016 | 15 | 0.040 |
Why?
|
| Brazil | 1 | 2016 | 69 | 0.040 |
Why?
|
| Choline | 1 | 2016 | 23 | 0.040 |
Why?
|
| Serotonin | 1 | 1998 | 218 | 0.040 |
Why?
|
| Fibroblast Growth Factor 8 | 1 | 2016 | 28 | 0.040 |
Why?
|
| Aspartic Acid | 1 | 2016 | 64 | 0.040 |
Why?
|
| PC12 Cells | 1 | 2016 | 115 | 0.040 |
Why?
|
| Creatine | 1 | 2016 | 23 | 0.040 |
Why?
|
| Deglutition Disorders | 1 | 1998 | 115 | 0.040 |
Why?
|
| Brain Mapping | 1 | 2000 | 548 | 0.040 |
Why?
|
| Membrane Potentials | 1 | 2018 | 435 | 0.040 |
Why?
|
| Brain Damage, Chronic | 1 | 1996 | 26 | 0.040 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2016 | 70 | 0.040 |
Why?
|
| Receptors, Androgen | 2 | 2009 | 113 | 0.040 |
Why?
|
| Epigenesis, Genetic | 1 | 2020 | 479 | 0.030 |
Why?
|
| Neuropsychological Tests | 2 | 2003 | 502 | 0.030 |
Why?
|
| Glutamine | 1 | 2016 | 76 | 0.030 |
Why?
|
| Anticonvulsants | 1 | 1997 | 126 | 0.030 |
Why?
|
| Naphthyridines | 1 | 2016 | 53 | 0.030 |
Why?
|
| Tissue Distribution | 1 | 2016 | 290 | 0.030 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 2 | 1993 | 135 | 0.030 |
Why?
|
| Polycomb Repressive Complex 2 | 1 | 2016 | 30 | 0.030 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2020 | 589 | 0.030 |
Why?
|
| Axons | 1 | 2016 | 174 | 0.030 |
Why?
|
| Adaptor Proteins, Vesicular Transport | 2 | 2006 | 49 | 0.030 |
Why?
|
| Peripheral Nerves | 1 | 1995 | 36 | 0.030 |
Why?
|
| Calcium Channels | 1 | 1997 | 182 | 0.030 |
Why?
|
| Polymorphism, Single-Stranded Conformational | 3 | 2001 | 29 | 0.030 |
Why?
|
| Ribosomal Protein S6 Kinases | 1 | 2015 | 10 | 0.030 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2016 | 318 | 0.030 |
Why?
|
| RNA, Viral | 1 | 2016 | 327 | 0.030 |
Why?
|
| Katanin | 1 | 2014 | 1 | 0.030 |
Why?
|
| Central Nervous System Neoplasms | 1 | 2016 | 81 | 0.030 |
Why?
|
| Amyloid beta-Peptides | 1 | 2016 | 203 | 0.030 |
Why?
|
| Multivariate Analysis | 1 | 2018 | 999 | 0.030 |
Why?
|
| Ouabain | 1 | 2015 | 24 | 0.030 |
Why?
|
| Cell Adhesion | 1 | 2016 | 420 | 0.030 |
Why?
|
| Glutamate Decarboxylase | 1 | 2015 | 32 | 0.030 |
Why?
|
| Pakistan | 1 | 2014 | 15 | 0.030 |
Why?
|
| Molecular Targeted Therapy | 1 | 2017 | 266 | 0.030 |
Why?
|
| Histone Deacetylases | 1 | 2015 | 63 | 0.030 |
Why?
|
| Platelet-Derived Growth Factor | 1 | 2014 | 67 | 0.030 |
Why?
|
| Up-Regulation | 1 | 2017 | 712 | 0.030 |
Why?
|
| Calcium | 2 | 1998 | 1156 | 0.030 |
Why?
|
| Lupus Coagulation Inhibitor | 1 | 1994 | 8 | 0.030 |
Why?
|
| Dendrites | 1 | 2014 | 99 | 0.030 |
Why?
|
| Electroporation | 1 | 2014 | 55 | 0.030 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2015 | 128 | 0.030 |
Why?
|
| Chromosome Inversion | 2 | 1997 | 47 | 0.030 |
Why?
|
| Pseudotumor Cerebri | 1 | 1994 | 16 | 0.030 |
Why?
|
| Liver Diseases | 3 | 2008 | 238 | 0.030 |
Why?
|
| Cell Survival | 1 | 2016 | 969 | 0.030 |
Why?
|
| Facial Paralysis | 1 | 1994 | 17 | 0.030 |
Why?
|
| Protein Multimerization | 1 | 2015 | 173 | 0.030 |
Why?
|
| Antiphospholipid Syndrome | 1 | 1994 | 20 | 0.030 |
Why?
|
| Vestibular Function Tests | 1 | 2013 | 13 | 0.030 |
Why?
|
| Gene Expression Profiling | 1 | 2019 | 1384 | 0.030 |
Why?
|
| Myoclonus | 1 | 1993 | 15 | 0.030 |
Why?
|
| MEF2 Transcription Factors | 1 | 2013 | 9 | 0.030 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 1 | 2013 | 68 | 0.030 |
Why?
|
| Dendritic Cells | 1 | 2016 | 425 | 0.030 |
Why?
|
| Hypesthesia | 1 | 2013 | 15 | 0.030 |
Why?
|
| Primary Myelofibrosis | 1 | 2013 | 56 | 0.030 |
Why?
|
| Movement Disorders | 2 | 2007 | 44 | 0.030 |
Why?
|
| Adrenocorticotropic Hormone | 1 | 1993 | 131 | 0.030 |
Why?
|
| Linkage Disequilibrium | 1 | 2014 | 473 | 0.030 |
Why?
|
| GTP-Binding Proteins | 1 | 1993 | 146 | 0.030 |
Why?
|
| Cerebrovascular Disorders | 1 | 1994 | 143 | 0.030 |
Why?
|
| Molecular Diagnostic Techniques | 1 | 2013 | 69 | 0.030 |
Why?
|
| Probability | 2 | 1992 | 355 | 0.030 |
Why?
|
| Rats, Wistar | 1 | 2013 | 297 | 0.030 |
Why?
|
| Blepharoptosis | 2 | 2007 | 11 | 0.030 |
Why?
|
| Basement Membrane | 1 | 2013 | 54 | 0.030 |
Why?
|
| Combined Modality Therapy | 1 | 2016 | 1685 | 0.030 |
Why?
|
| Corneal Diseases | 1 | 2013 | 32 | 0.030 |
Why?
|
| NIH 3T3 Cells | 1 | 2012 | 105 | 0.030 |
Why?
|
| Ectopia Cordis | 1 | 2012 | 1 | 0.030 |
Why?
|
| Gene Knockout Techniques | 1 | 2012 | 77 | 0.030 |
Why?
|
| Vesicular Transport Proteins | 1 | 2012 | 63 | 0.030 |
Why?
|
| PAX9 Transcription Factor | 1 | 2012 | 2 | 0.030 |
Why?
|
| Ligands | 2 | 2004 | 433 | 0.030 |
Why?
|
| Blotting, Western | 1 | 2014 | 782 | 0.030 |
Why?
|
| Genetic Complementation Test | 1 | 2012 | 97 | 0.030 |
Why?
|
| Genotyping Techniques | 1 | 2012 | 68 | 0.030 |
Why?
|
| Neoplasm Metastasis | 1 | 2016 | 1056 | 0.030 |
Why?
|
| Autoantibodies | 1 | 1993 | 267 | 0.030 |
Why?
|
| Wolff-Parkinson-White Syndrome | 1 | 2011 | 11 | 0.030 |
Why?
|
| Polysaccharides | 1 | 2012 | 89 | 0.030 |
Why?
|
| Extracellular Matrix | 1 | 2013 | 232 | 0.030 |
Why?
|
| Internet | 1 | 2014 | 312 | 0.030 |
Why?
|
| rab3 GTP-Binding Proteins | 1 | 2011 | 2 | 0.030 |
Why?
|
| Codon, Terminator | 1 | 2011 | 21 | 0.030 |
Why?
|
| Dyskinesias | 1 | 2011 | 7 | 0.030 |
Why?
|
| Molecular Typing | 1 | 2011 | 17 | 0.020 |
Why?
|
| Auditory Perception | 1 | 1992 | 96 | 0.020 |
Why?
|
| Fetal Death | 2 | 2002 | 56 | 0.020 |
Why?
|
| Touch | 1 | 1992 | 89 | 0.020 |
Why?
|
| Pentanes | 1 | 2010 | 4 | 0.020 |
Why?
|
| Promoter Regions, Genetic | 2 | 2009 | 937 | 0.020 |
Why?
|
| Hemiterpenes | 1 | 2010 | 6 | 0.020 |
Why?
|
| Jews | 1 | 2010 | 42 | 0.020 |
Why?
|
| Aged, 80 and over | 2 | 2018 | 6501 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2011 | 307 | 0.020 |
Why?
|
| Butadienes | 1 | 2010 | 33 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 11 | 1 | 2010 | 106 | 0.020 |
Why?
|
| Scalp | 1 | 1991 | 72 | 0.020 |
Why?
|
| Radionuclide Imaging | 1 | 1991 | 220 | 0.020 |
Why?
|
| Quantitative Trait Loci | 1 | 2014 | 576 | 0.020 |
Why?
|
| Respiratory Rate | 1 | 2010 | 20 | 0.020 |
Why?
|
| Occludin | 1 | 2010 | 66 | 0.020 |
Why?
|
| Cerebral Infarction | 1 | 1991 | 71 | 0.020 |
Why?
|
| Muscles | 1 | 1991 | 194 | 0.020 |
Why?
|
| Unfolded Protein Response | 1 | 2010 | 39 | 0.020 |
Why?
|
| Mice, Mutant Strains | 2 | 2004 | 229 | 0.020 |
Why?
|
| Age Factors | 1 | 2015 | 1849 | 0.020 |
Why?
|
| Plasmapheresis | 1 | 1990 | 26 | 0.020 |
Why?
|
| Neural Cell Adhesion Molecules | 1 | 2009 | 14 | 0.020 |
Why?
|
| Haemophilus influenzae | 1 | 1989 | 13 | 0.020 |
Why?
|
| Drosophila Proteins | 1 | 2014 | 488 | 0.020 |
Why?
|
| Algorithms | 1 | 2018 | 1830 | 0.020 |
Why?
|
| Bacterial Capsules | 1 | 1989 | 28 | 0.020 |
Why?
|
| Cerebral Ventriculography | 1 | 1989 | 8 | 0.020 |
Why?
|
| Clonazepam | 1 | 1989 | 3 | 0.020 |
Why?
|
| Hybrid Cells | 3 | 1997 | 72 | 0.020 |
Why?
|
| Open Reading Frames | 1 | 2009 | 117 | 0.020 |
Why?
|
| Diazepam | 1 | 1989 | 28 | 0.020 |
Why?
|
| Bone and Bones | 1 | 1991 | 265 | 0.020 |
Why?
|
| Epistasis, Genetic | 1 | 2009 | 86 | 0.020 |
Why?
|
| Oman | 1 | 2009 | 5 | 0.020 |
Why?
|
| Blotting, Southern | 3 | 1997 | 129 | 0.020 |
Why?
|
| Calcium-Binding Proteins | 1 | 2009 | 115 | 0.020 |
Why?
|
| Cleft Lip | 1 | 1989 | 15 | 0.020 |
Why?
|
| Postmortem Changes | 1 | 2008 | 8 | 0.020 |
Why?
|
| Cobblestone Lissencephaly | 1 | 2008 | 1 | 0.020 |
Why?
|
| Facial Bones | 2 | 1986 | 37 | 0.020 |
Why?
|
| Middle East | 1 | 2008 | 17 | 0.020 |
Why?
|
| Isoelectric Focusing | 1 | 2008 | 39 | 0.020 |
Why?
|
| Electrophoresis, Capillary | 1 | 2008 | 12 | 0.020 |
Why?
|
| Ear | 1 | 2008 | 18 | 0.020 |
Why?
|
| Visual Perception | 1 | 1992 | 319 | 0.020 |
Why?
|
| Egypt | 1 | 2008 | 13 | 0.020 |
Why?
|
| Blepharophimosis | 1 | 2007 | 1 | 0.020 |
Why?
|
| Replication Protein C | 1 | 2007 | 2 | 0.020 |
Why?
|
| Williams Syndrome | 1 | 2007 | 4 | 0.020 |
Why?
|
| Ataxia Telangiectasia | 1 | 2007 | 11 | 0.020 |
Why?
|
| Replication Protein A | 1 | 2007 | 16 | 0.020 |
Why?
|
| Gene Amplification | 2 | 2002 | 131 | 0.020 |
Why?
|
| Survival Rate | 1 | 2011 | 1860 | 0.020 |
Why?
|
| Ataxia Telangiectasia Mutated Proteins | 1 | 2007 | 52 | 0.020 |
Why?
|
| Orphan Nuclear Receptors | 1 | 2006 | 13 | 0.020 |
Why?
|
| Isotretinoin | 1 | 1987 | 23 | 0.020 |
Why?
|
| Tremor | 1 | 2007 | 22 | 0.020 |
Why?
|
| Matched-Pair Analysis | 1 | 2006 | 43 | 0.020 |
Why?
|
| DNA Repair Enzymes | 1 | 2007 | 52 | 0.020 |
Why?
|
| DNA Probes | 3 | 1992 | 77 | 0.020 |
Why?
|
| Adrenoleukodystrophy | 1 | 1986 | 3 | 0.020 |
Why?
|
| Ehlers-Danlos Syndrome | 1 | 2006 | 8 | 0.020 |
Why?
|
| Fragile X Syndrome | 1 | 2006 | 15 | 0.020 |
Why?
|
| Remission, Spontaneous | 1 | 2006 | 53 | 0.020 |
Why?
|
| Tretinoin | 1 | 1987 | 126 | 0.020 |
Why?
|
| Recombination, Genetic | 1 | 2008 | 439 | 0.020 |
Why?
|
| Software | 1 | 2010 | 654 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2012 | 2705 | 0.020 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2011 | 567 | 0.020 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 1 | 2007 | 153 | 0.020 |
Why?
|
| Neural Pathways | 1 | 2008 | 308 | 0.020 |
Why?
|
| Glutathione Reductase | 1 | 1985 | 7 | 0.020 |
Why?
|
| Reference Values | 1 | 2006 | 674 | 0.020 |
Why?
|
| Aging | 2 | 2001 | 691 | 0.020 |
Why?
|
| Calreticulin | 1 | 2005 | 13 | 0.020 |
Why?
|
| Primates | 1 | 2006 | 151 | 0.020 |
Why?
|
| Cockayne Syndrome | 1 | 2004 | 4 | 0.020 |
Why?
|
| Catalytic Domain | 1 | 2005 | 156 | 0.020 |
Why?
|
| Receptor, Metabotropic Glutamate 5 | 1 | 2004 | 5 | 0.020 |
Why?
|
| Genes, Lethal | 1 | 2004 | 53 | 0.020 |
Why?
|
| Pentosyltransferases | 1 | 2004 | 35 | 0.020 |
Why?
|
| Recovery of Function | 1 | 2006 | 272 | 0.020 |
Why?
|
| Erythrocytes | 1 | 1985 | 255 | 0.020 |
Why?
|
| Hair Follicle | 1 | 2004 | 26 | 0.020 |
Why?
|
| Antisense Elements (Genetics) | 1 | 2004 | 9 | 0.020 |
Why?
|
| Molecular Conformation | 1 | 2004 | 96 | 0.020 |
Why?
|
| Dihydrotestosterone | 1 | 2004 | 27 | 0.020 |
Why?
|
| RNA Splice Sites | 1 | 2004 | 53 | 0.020 |
Why?
|
| Sex Chromosome Disorders | 1 | 2004 | 2 | 0.020 |
Why?
|
| src Homology Domains | 1 | 2004 | 44 | 0.020 |
Why?
|
| Digestive System Abnormalities | 1 | 2004 | 13 | 0.020 |
Why?
|
| Turkey | 1 | 2004 | 20 | 0.020 |
Why?
|
| Genitalia, Female | 1 | 2004 | 25 | 0.020 |
Why?
|
| Central Nervous System | 1 | 2005 | 151 | 0.020 |
Why?
|
| Kidney Diseases | 1 | 2008 | 418 | 0.020 |
Why?
|
| Risk | 1 | 1985 | 674 | 0.010 |
Why?
|
| Coatomer Protein | 1 | 2003 | 2 | 0.010 |
Why?
|
| Decision Making | 1 | 2009 | 642 | 0.010 |
Why?
|
| Cyclin-Dependent Kinase 5 | 1 | 2003 | 12 | 0.010 |
Why?
|
| Dyneins | 1 | 2003 | 14 | 0.010 |
Why?
|
| Cyclin-Dependent Kinases | 1 | 2003 | 43 | 0.010 |
Why?
|
| Phosphoprotein Phosphatases | 1 | 2003 | 57 | 0.010 |
Why?
|
| Ultraviolet Rays | 1 | 2004 | 193 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2008 | 1673 | 0.010 |
Why?
|
| Immunoenzyme Techniques | 1 | 2003 | 303 | 0.010 |
Why?
|
| Luminescent Proteins | 1 | 2003 | 144 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 2005 | 912 | 0.010 |
Why?
|
| Trisomy | 1 | 2002 | 55 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 10 | 1 | 2002 | 47 | 0.010 |
Why?
|
| Calibration | 1 | 2002 | 99 | 0.010 |
Why?
|
| Green Fluorescent Proteins | 1 | 2003 | 305 | 0.010 |
Why?
|
| Testosterone | 1 | 2004 | 271 | 0.010 |
Why?
|
| Protein Kinase C | 1 | 2003 | 270 | 0.010 |
Why?
|
| Glucuronosyltransferase | 1 | 2003 | 184 | 0.010 |
Why?
|
| Diagnostic Errors | 1 | 2003 | 160 | 0.010 |
Why?
|
| Cognition Disorders | 1 | 2003 | 236 | 0.010 |
Why?
|
| Ribonucleoproteins, Small Nuclear | 1 | 2001 | 20 | 0.010 |
Why?
|
| Genetic Vectors | 1 | 2002 | 439 | 0.010 |
Why?
|
| Blotting, Northern | 1 | 2001 | 256 | 0.010 |
Why?
|
| Psychomotor Disorders | 1 | 2000 | 20 | 0.010 |
Why?
|
| Neural Conduction | 1 | 2000 | 69 | 0.010 |
Why?
|
| Nuclear Family | 1 | 2000 | 92 | 0.010 |
Why?
|
| Two-Hybrid System Techniques | 1 | 2000 | 55 | 0.010 |
Why?
|
| Demyelinating Diseases | 1 | 2000 | 68 | 0.010 |
Why?
|
| Dimerization | 1 | 2000 | 143 | 0.010 |
Why?
|
| Phylogeny | 1 | 2005 | 1137 | 0.010 |
Why?
|
| Dimercaprol | 1 | 1979 | 6 | 0.010 |
Why?
|
| Penicillamine | 1 | 1979 | 12 | 0.010 |
Why?
|
| Embryonic and Fetal Development | 1 | 1998 | 72 | 0.010 |
Why?
|
| Hypertension, Portal | 1 | 1979 | 47 | 0.010 |
Why?
|
| Copper | 1 | 1979 | 71 | 0.010 |
Why?
|
| Pyramidal Tracts | 1 | 1998 | 16 | 0.010 |
Why?
|
| Epithelial Cells | 1 | 2002 | 669 | 0.010 |
Why?
|
| Pigmentation | 1 | 1979 | 69 | 0.010 |
Why?
|
| Chromosome Fragility | 1 | 1998 | 4 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 2000 | 1014 | 0.010 |
Why?
|
| Cosmids | 1 | 1997 | 22 | 0.010 |
Why?
|
| Eye Movements | 1 | 1997 | 119 | 0.010 |
Why?
|
| Trinucleotide Repeats | 1 | 1997 | 31 | 0.010 |
Why?
|
| Restriction Mapping | 1 | 1997 | 157 | 0.010 |
Why?
|
| Necrosis | 1 | 1997 | 204 | 0.010 |
Why?
|
| Italy | 1 | 1996 | 106 | 0.010 |
Why?
|
| Biological Evolution | 1 | 2004 | 919 | 0.010 |
Why?
|
| DNA Methylation | 1 | 2001 | 628 | 0.010 |
Why?
|
| Neoplasms | 1 | 2011 | 2898 | 0.010 |
Why?
|
| Rabbits | 1 | 1997 | 636 | 0.010 |
Why?
|
| Orbit | 1 | 1995 | 37 | 0.010 |
Why?
|
| Mental Disorders | 1 | 1979 | 371 | 0.010 |
Why?
|
| Acetazolamide | 1 | 1994 | 9 | 0.010 |
Why?
|
| Diplopia | 1 | 1994 | 13 | 0.010 |
Why?
|
| Spinal Puncture | 1 | 1994 | 38 | 0.010 |
Why?
|
| Visual Fields | 1 | 1994 | 98 | 0.010 |
Why?
|
| Facial Nerve | 1 | 1994 | 33 | 0.010 |
Why?
|
| Headache | 1 | 1994 | 73 | 0.010 |
Why?
|
| Radioimmunoassay | 1 | 1993 | 155 | 0.010 |
Why?
|
| Drug Tolerance | 1 | 1993 | 63 | 0.010 |
Why?
|
| Steroids | 1 | 1994 | 177 | 0.010 |
Why?
|
| Fibroma | 1 | 1992 | 33 | 0.010 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 1994 | 206 | 0.010 |
Why?
|
| Fluorescence | 1 | 1991 | 102 | 0.010 |
Why?
|
| Cell Line, Transformed | 1 | 1991 | 154 | 0.010 |
Why?
|
| Immunoglobulin G | 1 | 1993 | 456 | 0.010 |
Why?
|
| Oligonucleotide Probes | 1 | 1990 | 39 | 0.010 |
Why?
|
| Parents | 1 | 1991 | 272 | 0.010 |
Why?
|
| Reproduction | 1 | 1988 | 195 | 0.000 |
Why?
|
| Antibodies, Monoclonal | 1 | 1993 | 1376 | 0.000 |
Why?
|
| Microbodies | 1 | 1986 | 7 | 0.000 |
Why?
|
| Adrenal Gland Diseases | 1 | 1986 | 13 | 0.000 |
Why?
|
| Macrophages | 1 | 1986 | 554 | 0.000 |
Why?
|
| Liver | 1 | 1986 | 1230 | 0.000 |
Why?
|